n(6)-carboxymethyllysine has been researched along with euk-134 in 1 studies
| Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (euk-134) | Trials (euk-134) | Recent Studies (post-2010) (euk-134) |
|---|---|---|---|---|---|
| 803 | 44 | 365 | 87 | 0 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, C; Gao, E; Koch, W; Lau, WB; Lian, K; Liu, J; Liu, Y; Lu, X; Ma, Y; Qu, Y; Sun, L; Tao, L; Wang, H; Wang, R; Xia, C; Xu, A; Yang, L | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and euk-134
| Article | Year |
|---|---|
The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury.
Topics: Acetophenones; Animals; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Free Radical Scavengers; Imines; Lysine; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide Synthase Type II; Organometallic Compounds; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA, Small Interfering; Salicylates; Superoxides; Thioredoxins; Tyrosine | 2012 |